ArticleClinical research in cardiology : official journal of the German Cardiac Society2026
Self-expanding intraannular transcatheter heart valve in tapered LVOT morphology - impact on deployment precision and periprocedural aortic prosthesis migration.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA tapered left ventricular outflow tract (LVOT) may influence outcomes in transcatheter aortic valve implantation (TAVI), especially regarding valve positioning and conduction disturbances. While this is established in cases of pure aortic regurgitation and stenosis with balloon-expandable valves, its effect in native high-grade aortic stenosis (AVS) using self-expandable (SE) valves remains unclear. This study evaluated the impact of tapered LVOT morphology on peri-procedural outcomes with a SE intraannular (IA) TAVI prosthesis.
methodsBetween June 2021 and April 2025, 354 patients with severe native AVS underwent TAVI using the SE IA TAVI prosthesis. Patients were stratified based on LVOT morphology (tapered vs. non-tapered). Clinical and hemodynamic outcomes, including incomplete periprocedural device migration (IPDM) and embolization, were compared between groups.
resultsTechnical success (96.9% tapered vs. 97.8% non-tapered, p = 0.727) and device success (92.9% vs. 89.4%, p = 0.373) were similarly high. IPDM occurred significantly more often in patients with a tapered LVOT (18.9% vs. 6.6%, p = 0.001). Overall, rates of embolization (0.8% vs. 2.6%, p = 0.429) and Valve-in-Valve procedures (0.8% vs. 1.8%, p = 0.658) were rare. Multivariate logistic regression identified a tapered LVOT morphology (OR 2.47; 95% CI 1.26-4.87; p = 0.009) and severe aortic valve eccentricity (OR 2.16; 95% CI 1.03-4.57; p = 0.042) as independent predictors for IPDM and embolization. The rate of permanent pacemaker implantation was comparable (17.4% vs. 18.0%; p = 1.000).
conclusionTAVI with the SE IA prosthesis demonstrated high procedural success across anatomical subgroups. However, a tapered LVOT was associated with a significantly increased risk of incomplete periprocedural device migration. In such cases, a slightly deeper implantation may enhance anchoring and stability. These findings highlight the critical importance of preprocedural anatomical assessment, particularly LVOT morphology, in optimizing outcomes for TAVI in native AVS.
Indexed as
Identifiers
42622673What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.